{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:34:29Z","timestamp":1767854069568,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T00:00:00Z","timestamp":1550620800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00415-019-09246-8","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T15:54:09Z","timestamp":1550678049000},"page":"1160-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Color perception impairment following optic neuritis and its association with retinal atrophy"],"prefix":"10.1007","volume":"266","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-6475","authenticated-orcid":false,"given":"Netta","family":"Levin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Devereux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atira","family":"Bick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"issue":"4","key":"9246_CR1","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/NXI.0000000000000135","volume":"2","author":"SL Galetta","year":"2015","unstructured":"Galetta SL et al (2015) Acute optic neuritis: unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinflamm 2(4):e135","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"9246_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1055\/s-0036-1582226","volume":"36","author":"JV Hanson","year":"2016","unstructured":"Hanson JV et al (2016) Optical coherence tomography in multiple sclerosis. Semin Neurol 36(2):177\u2013184","journal-title":"Semin Neurol"},{"issue":"9","key":"9246_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW et al (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 326(9):581\u2013588","journal-title":"N Engl J Med"},{"key":"9246_CR4","unstructured":"No authors listed (1997) Visual function 5 years after optic neuritis: experience of the optic neuritis treatment trial. The Optic Neuritis Study Group. Arch Ophthalmol 115(12):1545\u20131552. \n                    https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/642401"},{"key":"9246_CR5","first-page":"685","volume":"93","author":"B Katz","year":"1995","unstructured":"Katz B (1995) The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc 93:685\u2013708","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"9246_CR6","first-page":"2278","volume":"38","author":"ME Schneck","year":"1997","unstructured":"Schneck ME, Haegerstrom-Portnoy G (1997) Color vision defect type and spatial vision in the optic neuritis treatment trial. Invest Ophthalmol Vis Sci 38(11):2278\u20132289","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"9246_CR7","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1167\/iovs.14-16094","volume":"56","author":"MB Cranwell","year":"2015","unstructured":"Cranwell MB et al (2015) Performance on the Farnsworth-Munsell 100-Hue test is significantly related to nonverbal IQ. Invest Ophthalmol Vis Sci 56(5):3171\u20133178","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"9246_CR8","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00415-015-7876-3","volume":"262","author":"EJ Lampert","year":"2015","unstructured":"Lampert EJ et al (2015) Color vision impairment in multiple sclerosis points to retinal ganglion cell damage. J Neurol 262(11):2491\u20132497","journal-title":"J Neurol"},{"issue":"9","key":"9246_CR9","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1177\/1352458513517591","volume":"20","author":"EH Martinez-Lapiscina","year":"2014","unstructured":"Martinez-Lapiscina EH et al (2014) Colour vision impairment is associated with disease severity in multiple sclerosis. Mult Scler 20(9):1207\u20131216","journal-title":"Mult Scler"},{"issue":"7","key":"9246_CR10","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/1352458511431972","volume":"18","author":"P Villoslada","year":"2012","unstructured":"Villoslada P et al (2012) Color vision is strongly associated with retinal thinning in multiple sclerosis. Mult Scler 18(7):991\u2013999","journal-title":"Mult Scler"},{"issue":"2","key":"9246_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1167\/iovs.10-6283","volume":"52","author":"J Rabin","year":"2011","unstructured":"Rabin J, Gooch J, Ivan D (2011) Rapid quantification of color vision: the cone contrast test. Invest Ophthalmol Vis Sci 52(2):816\u2013820","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"9246_CR12","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1111\/aos.13495","volume":"96","author":"M Fujikawa","year":"2018","unstructured":"Fujikawa M et al (2018) Evaluation of clinical validity of the Rabin cone contrast test in normal phakic or pseudophakic eyes and severely dichromatic eyes. Acta Ophthalmol 96(2):e164\u2013e167","journal-title":"Acta Ophthalmol"},{"issue":"16","key":"9246_CR13","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","volume":"68","author":"LJ Balcer","year":"2007","unstructured":"Balcer LJ et al (2007) Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology 68(16):1299\u20131304","journal-title":"Neurology"},{"issue":"3","key":"9246_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","volume":"15","author":"R Raftopoulos","year":"2016","unstructured":"Raftopoulos R et al (2016) Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15(3):259\u2013269","journal-title":"Lancet Neurol"},{"issue":"10111","key":"9246_CR15","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"AJ Green","year":"2017","unstructured":"Green AJ et al (2017) Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet 390(10111):2481\u20132489","journal-title":"Lancet"},{"issue":"4","key":"9246_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical trials of new agents in multiple sclerosis. Neurology 46(4):907\u2013911","journal-title":"Neurology"},{"issue":"11","key":"9246_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"issue":"2","key":"9246_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/1352458514538110","volume":"21","author":"S Schippling","year":"2015","unstructured":"Schippling S et al (2015) Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Mult Scler 21(2):163\u2013170","journal-title":"Mult Scler"},{"issue":"24","key":"9246_CR19","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1212\/WNL.0000000000002774","volume":"86","author":"A Cruz-Herranz","year":"2016","unstructured":"Cruz-Herranz A et al (2016) The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 86(24):2303\u20132309","journal-title":"Neurology"},{"issue":"7","key":"9246_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","volume":"80","author":"EM Mowry","year":"2009","unstructured":"Mowry EM et al (2009) Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 80(7):767\u2013772","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"24","key":"9246_CR21","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1212\/WNL.0b013e31821f4602","volume":"76","author":"N Raz","year":"2011","unstructured":"Raz N et al (2011) Sustained motion perception deficit following optic neuritis: behavioral and cortical evidence. Neurology 76(24):2103\u20132111","journal-title":"Neurology"},{"issue":"6","key":"9246_CR22","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ajo.2010.01.011","volume":"149","author":"Y Almog","year":"2010","unstructured":"Almog Y, Nemet A (2010) The correlation between visual acuity and color vision as an indicator of the cause of visual loss. Am J Ophthalmol 149(6):1000\u20131004","journal-title":"Am J Ophthalmol"},{"issue":"Pt 3","key":"9246_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/brain\/119.3.723","volume":"119","author":"V Porciatti","year":"1996","unstructured":"Porciatti V, Sartucci F (1996) Retinal and cortical evoked responses to chromatic contrast stimuli. Specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis. Brain 119(Pt 3):723\u2013740","journal-title":"Brain"},{"issue":"Pt 9","key":"9246_CR24","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","volume":"124","author":"N Evangelou","year":"2001","unstructured":"Evangelou N et al (2001) Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 124(Pt 9):1813\u20131820","journal-title":"Brain"},{"issue":"3","key":"9246_CR25","first-page":"211","volume":"3","author":"D Toussaint","year":"1983","unstructured":"Toussaint D et al (1983) Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 3(3):211\u2013220","journal-title":"J Clin Neuroophthalmol"},{"issue":"Pt 6","key":"9246_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green AJ et al (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133(Pt 6):1591\u20131601","journal-title":"Brain"},{"issue":"14","key":"9246_CR27","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1177\/1352458513489757","volume":"19","author":"T Oberwahrenbrock","year":"2013","unstructured":"Oberwahrenbrock T et al (2013) Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Mult Scler 19(14):1887\u20131895","journal-title":"Mult Scler"},{"issue":"Pt 11","key":"9246_CR28","doi-asserted-by":"publisher","first-page":"e193","DOI":"10.1093\/brain\/awr095","volume":"134","author":"AU Brandt","year":"2011","unstructured":"Brandt AU et al (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134(Pt 11):e193 (author reply e194)","journal-title":"Brain"},{"issue":"Pt 1","key":"9246_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/brain\/awu335","volume":"138","author":"LJ Balcer","year":"2015","unstructured":"Balcer LJ et al (2015) Vision and vision-related outcome measures in multiple sclerosis. Brain 138(Pt 1):11\u201327","journal-title":"Brain"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09246-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09246-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:13:06Z","timestamp":1582139586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09246-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,20]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["9246"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09246-8","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,20]]},"assertion":[{"value":"17 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}